UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans

Current biology, 2000-09, Vol.10 (18), p.1092-1097

2000

Volltextzugriff (PDF)

Loss-of-function genetic diseases and the concept of pharmaceutical targets

Nature reviews. Genetics, 2007-05, Vol.8 (5), p.404-404

Segalat, L

2007

Volltextzugriff (PDF)

Description of International Caenorhabditis elegans Experiment first flight (ICE-FIRST)

Advances in space research, 2008-09, Vol.42 (6), p.1072-1079

2008

Volltextzugriff (PDF)

The SLO-1 BK Channel of Caenorhabditis elegans is Critical for Muscle Function and is Involved in Dystrophin-dependent Muscle Dystrophy

Journal of molecular biology, 2006-04, Vol.358 (2), p.387-395

2006

Volltextzugriff (PDF)

Modulation of serotonin-controlled behaviors by Go in Caenorhabditis elegans

Science (American Association for the Advancement of Science), 1995-03, Vol.267 (5204), p.1648-1648

1995

Volltextzugriff (PDF)

Muscular degeneration in the absence of dystrophin is a calcium-dependent process

Current biology, 2001-10, Vol.11 (21), p.1691-1694

2001

Volltextzugriff (PDF)

Patch clamp study of the UNC-105 degenerin and its interaction with the LET-2 collagen in Caenorhabditis elegans muscle

The Journal of physiology, 2004-06, Vol.557 (2), p.379-388

2004

Volltextzugriff (PDF)

Molecular, genetic and physiological characterisation of dystrobrevin-like ( dyb-1) mutants of Caenorhabditis elegans

Journal of molecular biology, 2001-03, Vol.307 (1), p.107-117

2001

Volltextzugriff (PDF)

In vitro interactions of Caenorhabditis elegans dystrophin with dystrobrevin and syntrophin

FEBS letters, 1999-11, Vol.461 (1), p.59-62

1999

Volltextzugriff (PDF)

Reply to De Luca

Neuromuscular disorders : NMD, 2004 (14)

Segalat, L.

2004

Volltextzugriff (PDF)

Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy

Human molecular genetics, 2009-11, Vol.18 (21), p.4089-4101

2009

Volltextzugriff (PDF)

Mos as a tool for genome-wide insertional mutagenesis in Caenorhabditis elegans: results of a pilot study

Nucleic acids research, 2004, Vol.32 (14), p.e117

2004

Volltextzugriff (PDF)

The L-Type Voltage-Dependent Ca2+ Channel EGL-19 Controls Body Wall Muscle Function in Caenorhabditis elegans

The Journal of cell biology, 2002-10, Vol.159 (2), p.337-347

2002

Volltextzugriff (PDF)

Pre-clinical study of 21 approved drugs in the mdx mouse

Neuromuscular disorders : NMD, 2011-05, Vol.21 (5), p.313-327

2011

Volltextzugriff (PDF)

Duchenne muscular dystrophy : stalled at the junction

European journal of human genetics : EJHG, 2005 (13), p.4-5

2005

Volltextzugriff (PDF)

T.P.2.01 Assessment of treatment efficiency using the mdx model: How to interpret the data?

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.580-580

2009

Volltextzugriff (PDF)

Dystrophin and functionally related proteins in the nematode Caenorhabditis elegans

Neuromuscular disorders : NMD, 2002-10, Vol.12, p.S105-S109

Ségalat, Laurent

2002

Volltextzugriff (PDF)

Mutations in the dystrophin-like dys-1 gene of Caenorhabditis elegans result in reduced acetylcholinesterase activity

FEBS letters, 1999-12, Vol.463 (3), p.270-272

1999

Volltextzugriff (PDF)

Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission

Neurogenetics, 1998-12, Vol.2 (1), p.61-72

1998

Volltextzugriff (PDF)

Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans

Neuromuscular disorders : NMD, 2004-06, Vol.14 (6), p.365-370

2004

Volltextzugriff (PDF)

Patterns of Selection Against Transposons Inferred From the Distribution of Tc1, Tc3 and Tc5 Insertions in the mut-7 Line of the Nematode Caenorhabditis elegans

Genetics (Austin), 2003-11, Vol.165 (3), p.1127-1135

2003

Volltextzugriff (PDF)

Metabolic profiling strategy of caenorhabditis elegans by whole-organism nuclear magnetic resonance

Journal of proteome research, 2009, Vol.8 (5), p.2542-2550

2009

Volltextzugriff (PDF)

Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18)

Genomics (San Diego, Calif.), 2006-11, Vol.88 (5), p.642-649

2006

Volltextzugriff (PDF)

T.P.2.02 Effect of 20 approved drugs on a wide range of mdx parameters

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.580-580

2009

Volltextzugriff (PDF)

G.P.13.01 DYC-1 and ZYX-1, new actors of muscle degeneration in Caenorhabditis elegans

Neuromuscular disorders : NMD, 2009-09, Vol.19 (8), p.639-639

2009

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(56)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Neuromuscular Disorders : Nmd
(12)
Genetics
(4)
Journal Of Molecular Biology
(4)
Febs Letters
(3)
Science
(3)
Current Biology
(2)
European Journal Of Human Genetics : Ejhg
(2)
Journal Of Physiology
(2)
M.S. Médecine Sciences
(2)
Neuron
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans

Loss-of-function genetic diseases and the concept of pharmaceutical targets

Description of International Caenorhabditis elegans Experiment first flight (ICE-FIRST)

The SLO-1 BK Channel of Caenorhabditis elegans is Critical for Muscle Function and is Involved in Dystrophin-dependent Muscle Dystrophy

Modulation of serotonin-controlled behaviors by Go in Caenorhabditis elegans

Muscular degeneration in the absence of dystrophin is a calcium-dependent process

Patch clamp study of the UNC-105 degenerin and its interaction with the LET-2 collagen in Caenorhabditis elegans muscle

Molecular, genetic and physiological characterisation of dystrobrevin-like ( dyb-1) mutants of Caenorhabditis elegans

In vitro interactions of Caenorhabditis elegans dystrophin with dystrobrevin and syntrophin

Reply to De Luca

Evaluation of the therapeutic potential of carbonic anhydrase inhibitors in two animal models of dystrophin deficient muscular dystrophy

Mos as a tool for genome-wide insertional mutagenesis in Caenorhabditis elegans: results of a pilot study

The L-Type Voltage-Dependent Ca2+ Channel EGL-19 Controls Body Wall Muscle Function in Caenorhabditis elegans

Pre-clinical study of 21 approved drugs in the mdx mouse

Duchenne muscular dystrophy : stalled at the junction

T.P.2.01 Assessment of treatment efficiency using the mdx model: How to interpret the data?

Dystrophin and functionally related proteins in the nematode Caenorhabditis elegans

Mutations in the dystrophin-like dys-1 gene of Caenorhabditis elegans result in reduced acetylcholinesterase activity

Mutations in the Caenorhabditis elegans dystrophin-like gene dys-1 lead to hyperactivity and suggest a link with cholinergic transmission

Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans

Patterns of Selection Against Transposons Inferred From the Distribution of Tc1, Tc3 and Tc5 Insertions in the mut-7 Line of the Nematode Caenorhabditis elegans

Metabolic profiling strategy of caenorhabditis elegans by whole-organism nuclear magnetic resonance

Gene expression profiling studies on Caenorhabditis elegans dystrophin mutants dys-1(cx-35) and dys-1(cx18)

T.P.2.02 Effect of 20 approved drugs on a wide range of mdx parameters

G.P.13.01 DYC-1 and ZYX-1, new actors of muscle degeneration in Caenorhabditis elegans

Suchergebnisse filtern